Gabriela Gomez is an epidemiologist/health economist at the Amsterdam Institute for Global Health and Development and Department of Global Health, University of Amsterdam. She leads operational research projects evaluating the impact of prevention programs for key populations in sub-Saharan Africa. These programs include HIV prevention for truck drivers and sex workers in Zambia, Zimbabwe and South Africa; cardiovascular disease prevention in slums in Kenya and rural Nigeria; expansion of antiretroviral services (PrEP and immediate treatment) for female sex workers in South Afrcia, and ante-natal care interventions in rural Nigeria.
She is currently a visiting research fellow in the Department of Global Health and Development at the London School of Hygiene and Tropical Medicine, where she has developed a cost-effectiveness model to evaluate the scale-up of new shortened regimens for first line treatment of TB in Brazil, Bangladesh, Tanzania and South Africa. She is currently part of the TB Modelling and Analysis consortium, funded by the Bill and Melinda Gates Foundation, where she works on several projects evaluating the feasibility of End TB Strategy’s global goals in China, South Africa, and India.
During the last three years, she has been a consultant in the division of Reproductive Health and Research at the World Health Organisation. Gabriela obtained her PhD in Infectious Disease Epidemiology from Imperial College London and overall she has over ten years’ experience working with vulnerable populations in marginalized environments.
Impact evaluation of a community based intervention for prevention of cardiovascular diseases in the slums of Nairobi: the SCALE UP study
Authored by: van de Vijver Steven, Oti Samuel Oji, Gomez Gabriela B., Agyemang Charles, Egondi Thaddaeus, van Charante Eric Moll, Brewster Lizzy M., Hankins Catherine, Tanovic Zlata, Ezeh Alex, Kyobutungi Catherine, Stronks Karien.
In: GLOBAL HEALTH ACTION 9, 2016, p.30922 .
Impact evaluation of a community‑based intervention for prevention of cardiovascular diseases in the slums of Nairobi: the SCALE‑UP study
Authored by: van de Vijver Steven, Oti Samuel Oji, Gomez Gabriela B., Agyemang Charles, Egondi Thaddaeus, van Charante Eric Moll, Brewster Lizzy M., Hankins Catherine, Tanovic Zlata, Ezeh Alex, Kyobutungi Catherine, Stronks Karien
In: GLOBAL HEALTH ACTION 9, 2016, p.30922‑.
A simplified cost‑effectiveness model to guide decision‑making for shortened anti‑tuberculosis treatment regimens
Incorporating Demand and Supply Constraints into Economic Evaluations in Low‑Income and Middle‑Income Countries
Shortened first‑line TB treatment in Brazil: potential cost savings for patients and health services
Authored by: Trajman Anete, Bastos Mayara Lisboa, Belo Marcia, Calaça Janaína, Gaspar Júlia, Dos Santos Alexandre Martins, Dos Santos Camila Martins, Brito Raquel Trindade, Wells William A., Cobelens Frank G., Vassall Anna, Gomez Gabriela B.
In: BMC HEALTH SERVICES RESEARCH 16(1), 2016, p.27‑.
The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa
Authored by: Knight GM, Gomez G. B., Dodd PJ, Dowdy David, Zwerling Alice, Wells William A., Cobelens F. et al.
In: PloS One, 2015
Double burden of disease in the slums of Kenya
Authored by: Oti Samuel O.
Thesis Universiteit van Amsterdam
Promotor: K. Stronks
Copromotor(s): C. Kyobutungi, C.O. Agyemang, G.B. Gomez
Date of thesis defense: 14/10/2015The goal of this thesis was to provide evidence of a double burden of disease inthe slums of Nairobi and to make a case for an integrated health systems approach to tackling this situation. A double burden of disease refers to the coexistence of a high burden of communicable and non-communicable diseases in the same population. An integrated health system is one that is responsive to the burden ofdisease in any setting whether communicable or non-communicable. Read more
Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria
Authored by: Gomez G. B., Foster N, Brals D, Nelissen HE, Bolarinwa OA, Hendriks ME, Boers AC, van Eck D, Rosendaal NT, Adenusi P, Agbede K, Akande TM, Boele van Hensbroek M., Wit F. W., Hankins CA, Schultsz C
In: PloS One, 2015
Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis
Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria.
Authored by: Hendriks ME, Bolarinwa Oladimeji Akeem, Nelissen HE, Alexander C. Boers, Gomez G. B., Tan SS, Redekop William, Adenusi Peju, Lange J. M., Agbede Kayode, Akande Tanimola M., Schultsz Constance
In: JOURNAL OF HYPERTENSION 33(2), 2015, p.376‑384.
Risk Pathways for Gonorrhea Acquisition in Sex Workers: Can We Distinguish Confounding From an Exposure Effect Using A Priori Hypotheses?
Authored by: Gomez G. B., Ward H, Garnett G.P.
In: The Journal of Infectious Diseases, 2014
Availability, price and affordability of anti-tuberculosis drugs in Europe: A TBNET survey.
Authored by: Günther Gunar, Gomez Gabriela B., Lange Christoph, Rupert Stephan, van Leth Frank
In: EUROPEAN RESPIRATORY JOURNAL 45(4), 2015, p.1081‑1088.
Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.
Authored by: Fofana MO, Knight GM, Gomez G. B., White RG, Dowdy David
In: Plos One, 2014
Low levels of HIV test coverage in clinical settings in the U.K.: a systematic review of adherence to 2008 guidelines.
Step-by-step guideline for disease-speci-c costing studies in low- and middle-income countries: a mixed methodology
Authored by: Hendriks Marleen E., Piyali Kundu, Alexander C. Boers, Bolarinwa Oladimeji Akeem, Mark J. te Pas, Akande Tanimola M., Kayode Agbede, Gomez Gabriela B., Redekop William, Schultsz Constance, Siok Swan Tan
In: Global Health Action, 2014
The Cost and Cost-Effectiveness of Scaling up Screening and Treatment of Syphilis in Pregnancy: A Model
Authored by: James G. Kahn, Aliya Jiwani, Gomez Gabriela B., Hawkes SJ, Harrell W. Chesson, Broutet N, Kamb M L, Newman L M
In: PLoS ONE 9(1): e87510, 2014
Early Antenatal Care: Does It Make a Difference to Outcomes of Pregnancy Associated with Syphilis- A Systematic Review and Meta-Analysis.
Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data.
The impact of syphilis on adverse pregnancy outcomes: A systematic literature review and meta-analysis.
Authored by: Gomez Gabriela B., Kamb M L, Newman L M, Mark J, Hawkes SJ
In: Bull World Health Organ, 2013, 217–226
North-South Corridor Demonstration Project: Ethical and Logistical Challenges in the Design of a Demonstration Study of Early Antiretroviral Treatment for Long Distance Truck Drivers along a Transport Corridor through South Africa,Zimbabwe and Zamb
The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies
Do support groups members disclose less to their partners- The dynamics of HIV disclosure in four African countries
Authored by: Hardon Anita, Gomez Gabriela B., Vernooij Eva, Desclaux Alice, Wanyenze Rhoda K., Ky-Zerbo Odette, Kageha Emmy, Namakhoma Ireen, Kinsman John, Spronk Clare, Meij Edgar, Neuman Melissa, Obermeyer Carla Makhlouf
In: BMC PUBLIC HEALTH 13, 2013, p.589-
Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya
Are Thai MSM Willing to Take PrEP for HIV Prevention- An Analysis of Attitudes, Preferences and Acceptance
Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study
The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study
Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study